Used primarily in pharmaceutical research as a key intermediate in the synthesis of central nervous system agents, particularly those targeting neurological and psychiatric disorders. Its structural framework supports the development of compounds with affinity for neurotransmitter receptors, including dopamine and serotonin receptors. Commonly employed in the preparation of analogs for studying addiction, depression, and neurodegenerative diseases. Also utilized in the design of selective ligands for nicotinic acetylcholine receptors, making it valuable in the discovery of treatments for cognitive impairments and pain management.